Consultant cardiac surgeons, Mr Neil Moat and Mr Cesare Quarto, have won two international awards for presentations about their work on a world-first transcatheter heart valve implantation to treat mitral regurgitation (a leaking mitral valve).
Mr Moat won the Dr Martin Leon prize for his presentation at the Heart Valve Society Meeting in Monaco in May, while Mr Quarto won the Robert Emery Young Investigator Award for his presentation at the International Society for Minimally Invasive Cardiothoracic Surgery 2015 annual meeting in Berlin in June.
The Tendyne Transcatheter Mitral Valve system, for patients not suitable for open heart surgery, was implanted for the first time at Royal Brompton Hospital in a minimally invasive procedure. The valve is placed into the patient’s beating heart via a catheter through a small incision between the ribs and without the use of cardiopulmonary bypass, commonly known as a heart-lung machine.
The first patient to be implanted with the valve, 68-year-old Margaret Mann, made a rapid recovery and the team has gone on to successfully implant the Tendyne device in three other patients for whom surgery was not an option.
Mr Quarto said: "We are delighted to have been recognised for our work in developing this groundbreaking procedure. For me, it was a great honour to win the Young Investigator Award - thanks to Mr Moat and the team for supporting and encouraging me. This recognition also highlights the Trust’s position at the forefront of cutting-edge and pioneering treatments for heart disease."
In January, the Daily Mail reported on the novel procedure and featured interviews with Mr Moat and Mrs Mann. To read the article, click here.
Back to BRU news